There is absolutely no doubt about Australia’s affection for light commercial vehicles, commonly referred to as utes. Each month, the top five new vehicle sales list features at least two utility vehicles, with the Toyota Hilux and Ford Ranger typically topping the list.

Now, finally, the first electric ute is on offer in Australia – with the launch and unveiling of the LDV eT60, with an 88.5kWh battery, a modest 330km range – and a jaw-dropping ride price of $88,431 for tradesmen, or $92,000 for other mortals.

LDK, which is also launching an electric delivery van, the eDeliver 9, hails the arrival of the eT60 as a “watershed moment” in the Australian automotive industry.

Until now, the only electric vans available were bespoke conversions, and LDK decided to hit the market before the “big names” such as the Rivian, GM electric Hummer and Tesla Cybertruck came to market. Australia.

“We are an OEM offering Australia’s first electric utility and everything that goes with it: a nationwide dealer network, factory backed service and warranty, and a major spares operation for manage our rapidly growing car park,” says LDV Managing Director Dinesh Chinnappa.

“And now we have Australia’s first electric utility – and that’s why we’ve entered into fleet agreements with major global and Australian companies, federal, state and local governments and fleet operators who are committed manage their activities in a more environmentally friendly way.

Watershed moment for the electric vehicle industry

“This watershed moment in Australia’s motoring history marks a turning point in the electrification of commercial vehicles – and proves that weekends don’t have to end just yet.”

The Driven was one of many motoring journals invited to drive the eT60 and our report can be found here, but here are some of the key details.

The ute is powered by a single motor which drives the rear wheels. This motor produces 130 kW of power and 310 Nm of torque.

The configuration has a nominal consumption of 21.3 kWh/100 km. That’s pretty good considering the dimensions of this ute which sit at:

• 5365mm in length
• 1900mm wide
• 1809mm tall

For comparison, the MG ZS EV – a cheaper electric SUV – has a consumption of 18.6 kWh/100 km.

With this consumption, the eT60 comes with reasonable charging speeds and can be quickly charged by direct current from 20% to 80% in 45 minutes.

The eT60 ute is equipped with a CCS2 DC fast charging port so it can be charged during lunch breaks on one of the growing DC fast chargers across the country.

Towing

This utility also has a towing capacity of 1,000kg, which isn’t best in class among ICE utilities, but it gets the job done for many looking to tow smaller trailers with implements. But that halves the range.

Security

On the safety side, the ute is equipped with:

• 6 airbags
• Electronic Stability Program (ESP)
• Hill Start Assist (HAS)
• Reversing camera with parking aid
• LED daytime running lights.

This security equipment is comparable to most traditional ICE utilities.

Interior

Inside, the cabin features artificial leather stitched seats for the front and rear rows. The seating position of the front seats can be adjusted electronically without having to adjust them manually.

The build quality was quite good and has less plastic-like trim materials compared to what you find in many ICE utilities.

This ute is also equipped with a 10.25-inch infotainment touchscreen which comes standard with Apple CarPlay as well as Smartphone connectivity.

There are front and rear USB ports for charging phones and other devices. The seat pocket and glove compartment also provide functional space.

Warranty and maintenance

On the warranty side, LDV offers a 5-year/160,000 km warranty on the vehicle and an 8-year/160,000 km warranty on the battery.

This gives many customers and fleets good peace of mind when considering transitioning fleets to an electric vehicle. For comparison, a Ford Ranger ICE ute has a 5-year vehicle warranty and no powertrain add-ons.

Service can be performed at any of 95 LDV dealers across Australia. The eT60 requires service once every 2 years or 30,000 km, whichever comes first.

Price

The LDV eT60 is priced at $88,431 drive-thru for ABN holders, or a recommended retail price of $92,990 drive-thru for private buyers. High end paints other than white are $500 more.

It’s about double the cost of the company‘s fossil fuel utilities in Australia, but it insists it’s facing strong customer interest.

Driven’s view: Electric vehicles are rare and require larger and more expensive batteries. As this segment grows, availability is expected to increase, bringing with it the cost of manufacturing and delivering electric vehicles in Australia.

The LDV eT60 is the first of its kind and is well equipped to meet the needs of many ute owners on our roads.

Innovative products can be expensive when first launched. Think of the iPhone or the first Teslas that didn’t stop some people from trying it out.

Electric aircraft maker Archer has unveiled its Archer Midnight eVTOL and announced that it will serve New York from 2025.

The Archer Midnight electric plane is one of many planes launched by startups promising to revitalize the “mobility industry”. But comparatively, Archer goes about it conservatively. The company does not promise self-driving flights to a city near you, nor does it promise that its plane will take you around the world. The Archer Midnight is a piloted electric aircraft designed for fast commutes in congested cities.

The Archer Midnight is a fairly small aircraft, carrying only four passengers and a pilot. But the electric plane has a total payload of 1000 pounds, which allows for a large amount of cargo. The Midnight uses electric vertical take-off and landing (eVTOL) technology to limit its need for airstrips, and with its swivel motors it can reach 150 mph. With a total range of 100 miles, the CEO says Midnight has enough range for many quick commutes in congested cities like New York and Los Angeles.

The production-ready version of the Archer Midnight is a big milestone for the company, as it only has to wait for safety certification (hopefully in 2024). Shortly thereafter, in 2025, Archer will begin service between New York City and Newark International Airport, with many routes planned for the future.

A point of clarification, while Archer has already flight tested its Archer Maker aircraft earlier this year, it is unclear if the same tests have already been performed with the Archer Midnight.

After discussing the company’s timeline, Mr. Goldstien turned to the technical hurdles the electric plane design had overcome. Julien Montousse, automotive designer turned Archer, aerospace designer, cited visibility, comfort and ease of access as his top concerns. The Archer Midnight achieves unrivaled views through the use of carbon fiber; the lightweight material allowing Archer to use more glass (a relatively heavy material) in the cabin.

Archer also aimed to make their aircraft easy to assemble and comfortable to travel. These challenges have been overcome by the quiet operation and compact design of the electric motors which maximize interior space. The landing gear has also been specially designed to keep the floor of the aircraft as low as possible, making entry and exit comfortable and easy.

The final challenge that was touched on briefly was affordability. Archer hopes the Midnight can be used by a lot of people, not just the ultra-rich. However, it is still unclear whether the company has achieved this goal without pricing information.

Electric aviation continues to grow and amaze with the constant release of new technologies. With Archer’s clear path to certification and implementation, we may be closer than ever to personalized electric flight experiences. However, with a long road to FAA certification ahead of them, don’t hold your breath for service just yet.

What do you think of the article ? Do you have any comments, questions or concerns? Email me at [email protected]. You can also reach me on Twitter @WilliamWritin. If you have topical advice, write to us at [email protected]!

Archer Midnight eVTOL Electric Aircraft Unveiled: Service in NYC in 2025

MUNICH – PA Engines (affiliate ‘Sono Group SA,’ NASDAQ: SEV), the Munichsolar mobility OEM and the well-known German company Bosch have agreed to cooperate on an agreement Europe-large network of auto repair shops.

– The Munich-based Solar Mobility OEM Sono Motors and the long-established German company Bosch Collaborate in the maintenance and repair of Sion as part of the Bosch Car service workshop concept.

– During the launch phase in Germany50 Bosch Car services will be trained and qualified as Authorized Service Centers for Sion, Sound Motors Solar electric vehicle. Other European countries will follow during the subsequent deployment.

– In addition, Sono Motors intends to provide all approx. 22,000 Independent auto repair shops in Germany with an abbreviated version of the Sion factory service manual.

As part of the Bosch Car Service workshop concept, all maintenance and repair services will be offered according to modern standards. Owners of the Sion, Sono Motor’s solar electric vehicle, will be able to use all the services offered by participating auto repair shops, including repair, service, maintenance and warranty services. In other words, thanks to the Bosch Integration of the Car Service network, Sion owners will be able to more easily find a competent repair partner in Europe. The 50 qualifiers in total Bosch Car Services to be formed in the launch phase will be distributed throughout Germany so that major cities and rural areas are covered. Additional qualified service centers will be added during subsequent roll-out to create a comprehensive service network available in many European countries.

Highly qualified Bosch Partner workshops

The staff at Bosch partner workshops will receive comprehensive pre-training from PA Engines after which they will be authorized to carry out repairs on the high voltage, photovoltaic and security systems with the assistance, if necessary, of the Sono Motors technical field service. All repairs, warranty and proactive services can only be performed by authorized partner workshops, which will be recognizable by a sign reading “Sono Motors Service Partner” outside the auto repair shops. To find the right repair shop even easier, PA Engines plans to provide a workshop finder on its website.

“We are proud of our strategic partnership with Bosch Car Service, a professional partner for all things automotive, which we believe demonstrates the reputation we earn as an OEM. The Bosch brand represents the highest quality, and the workshop experts at Bosch Car Service carries out its maintenance and repair work according to modern standards. All this does Bosch an ideal partner for PA Engines in order to offer our customers comprehensive services, Europe-services at scale,” says Laurin HahnCEO and co-founder of PA Engines.

“We have found in Sono Motors an innovative partner who is exploring the exciting field of solar electric mobility. The innovative technology and skills provided by PA Engines to Bosch The Car Service network ensures that customers will receive reliable services for their vehicles. This further underlines the Electric Vehicle competence of Bosch Car Service and also helps to win and retain new customer groups.’ said Thomas WinterVice President Workshop Concepts at Robert Bosch.

The cooperation between PA Engines and Bosch includes full repair, service and proactive service work. In addition, PA Engines encourages all Sion owners to do their own repairs whenever possible. “For us, Sion is a symbol of independence. Of course, you should take your car to a repair shop if something goes wrong, but we want our customers to feel confident enough to do minor repairs themselves, such as replacing a light bulb or a wiper blade,” says Laurin Hahn. As an accompanying measure, PA Engines plans to provide tutorials for some DIY interviews on its website.

ON BOSCH AUTOMOTIVE SPARE PARTS

The Automotive Aftermarket (AA) supplies spare and repair shops around the world with modern diagnostic and repair equipment and a wide range of spare parts – from new and exchange parts to repair solutions – for passenger cars and vehicles utilities. Its product portfolio includes products manufactured as Bosch original equipment, products developed in-house and manufactured specifically for the aftermarket, as well as services. Approximately 13,000 associates in more than 150 countries, along with a global logistics network, ensure that spare parts reach customers quickly and on time. AA provides test and repair shop technology, diagnostic software, training and information services. In addition, the division is responsible for the ‘Bosch Service’ repair shop franchise, one of the largest independent repair shop chains in the world, with some 15,000 shops and more than 1,000 ‘AutoCrew’ partners.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements. The words ‘expect’, ‘anticipate’, ‘intend’, ‘plan’, ‘estimate’, ‘aim’, ‘anticipate’, ‘project’, ‘target’, ‘will’ and similar expressions (or the negative thereof) identify some of these forward-looking statements. These forward-looking statements are statements about the Company‘s current intentions, beliefs or expectations. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause results, performance or achievements to be materially impaired. real of the Company. different from those expressed or implied by such forward-looking statements. These risks, uncertainties and assumptions include, but are not limited to (i) the impact of the global COVID-19 pandemic on the global economy, our industry and markets and our business, (ii) risks related our limited operating history, the deployment of our business and the timing of expected commercial milestones, including our ability to complete our vehicle engineering and start of production on time and on budget and the risks associated with future operating results, (iii) risks relating to our unproven ability to develop and produce vehicles and with expected or announced specifications, including range and risks relating to required financing, (iv) risks relating to our ability to monetize our solar technology, (v) risks related to the uncertainty of projected financial information regarding our business, including the conversion of reservations to binding orders s, (vi) the effects of competition and the pace and depth of adoption of electric vehicles generally and our key vehicles in particular on our future business and (vii) changes in regulatory requirements, government incentives and fuel and energy prices. For additional information regarding some of the risks, uncertainties and assumptions that could affect our forward-looking statements, please see the Company’s filings with the US Securities and Exchange Commission (‘SECOND‘), which are accessible on the DRY website at www.sec.gov and on our website at ir.sonomotors.com. Many of these risks and uncertainties relate to factors beyond the Company’s ability to control or accurately estimate, such as the actions of regulatory authorities and other factors. Readers should therefore not place undue reliance on such statements, particularly in connection with any contract or investment decision. Except as required by law, the company undertakes no obligation to update these forward-looking statements.

(MENAFN-Mid-East.Info)

“Al-Futtaim Auto Centers” will continue to offer the same superior after-sales solutions and trustworthy automotive maintenance associated with the Al-Futtaim Automotive brand.

The announcement comes with the unveiling of five new locations and a new mobile service option for all makes and models of cars in the UAE.

Dubai, UAE: Al-Futtaim Automotive today announced the rebranding of all FastFit locations to Al-Futtaim Auto Centers, an existing brand within the group that services and services all makes and models of vehicles available in the United Arab Emirates. This exciting change comes with the announcement of five new locations in the United Arab Emirates as well as a mobile service option that will meet growing demand across the country while providing added convenience for Al-Futtaim customers. in line with its customer-centric approach.

The goal of Al-Futtaim Automotive Centers is to provide an unparalleled experience for consumers who require automotive services or service-related products for their vehicle, regardless of make or model. With confidence and convenience at the heart of the offering, the center strives to keep customers safe while providing them with a wide range of affordable, no-compromise automotive services, including new tires, balancing and wheel alignment, batteries and brakes, maintenance, AC gas, tinted windows, vating, accessories and more.

In addition, ten new Al-Futtaim Automotive Centers will open during the rest of the year and until 2023, which will increase activities by 70%. These include locations in Dubai Investments Park and Ajman which opened in September 2022 with the opening of Dubai Silicon Oasis in December and Dubai Festival City and Dalma Mall, Abu Dhabi in 2023, increasing maintenance by around 44,000 vehicles to 75,000 by the end of next year.

Along with the new locations, which will number 25 by the end of 2023, Al-Futtaim Auto Center will also offer a modern, state-of-the-art and fully equipped mobile service, where service and maintenance vehicles capable of servicing, oil changes, tires, batteries, air conditioning can be shipped directly to a customer’s home or place of business for convenience and ease.

Speaking about the expansion and rebranding, David McNamara, Level 2 Aftersales Manager at Al-Futtaim Automotive said, “The Al-Futtaim name is synonymous with quality and is synonymous across the Arab Emirates. united by impeccable customer service. With that in mind, it was natural to rebrand Fastfit locations to Al-Futtaim Auto Centers throughout the region. The core values ​​of Al-Futtaim Automotive Centers are based on affordability, trust and convenience and they strive to provide customers with the best possible experience and treatment with every visit on any make or model. of vehicle. Al-Futtaim’s entrepreneurial spirit and relentless customer focus allows us to continue to expand and diversify our offering with the additional locations, as well as provide mobile service to meet all of our customers’ needs. .

Finally, continuing the digital innovation, growth and development of Al-Futtaim Automotive, Al-Futtaim Auto Center launched a new comprehensive e-commerce website in June 2022, providing customers with the ability to purchase and reserve a myriad of online services, including tire fitting or maintenance with the choice at home, at work (mobile vehicles) or at one of the Al-Futtaim Automotive Center locations.

Notes to Editors:

All FastFit locations will be renamed Al-Futtaim Auto Centers

Service centers can service and repair all makes and models of vehicles available in the UAE

Opening of ten new Al-Futtaim automotive centers during the rest of the year and until 2023, which will increase the activity by 70%

25 service points by the end of 2023

Increase maintenance of approximately 44,000 vehicles to 75,000 by the end of 2023

About Al-Futtaim Automotive

Al-Futtaim Automotive, one of the five main operating divisions of the UAE-based Al-Futtaim Group of Companies, is a conglomerate of automotive-related businesses, franchising some of the world’s most recognized automotive brands and services .

Present in 10 countries in the Middle East, Asia and Africa and with around 9,000 associates, the group’s services, headquartered in the United Arab Emirates, cover the distribution of new and used vehicles, manufacturing, rental and after-sales.

Ranging from passenger cars to SUVs, utility vehicles, industrial and construction equipment as well as motorcycles and quads, Al-Futtaim Automotive Group provides an integrative customer-centric experience for motorists, fleet operators and contractors, and strives to become the leader in made-to-measure. tailor-made mobility solutions.

About Al-Futtaim Group

Established in the 1930s as a trading company, the Al-Futtaim Group is today one of the most diverse and progressive private regional companies, headquartered in Dubai, United Arab Emirates.

Structured into five operational divisions; automotive, financial services, real estate, retail and healthcare; Employing over 33,000 people in over 20 countries in the Middle East, Asia and Africa, we partner with over 200 of the world’s most admired and innovative brands.

Al-Futtaim Group’s entrepreneurial spirit and unwavering customer focus allow the organization to continue to grow and develop; meet the changing needs of our customers within the societies in which we operate.

By upholding our values ​​of Respect, Excellence, Collaboration and Integrity, Al-Futtaim Group continues to enrich the lives and aspirations of our customers every day.

The prevalence of obesity and cardiovascular disease is increasing rapidly worldwide. Adoption of unhealthy and hectic lifestyle, rapid increase in heart diseases, are the factors driving the atrial fibrillation market.

CITY OF JERSEYNew Jersey , November 9, 2022 /PRNewswire/ — Verified Market Research recently released a report, “Atrial Fibrillation Market” By procedures (pharmacological drugs, non-pharmacological treatment) and by geography.

According to an in-depth study conducted by Verified Industry Research on the Atrial Fibrillation Market, the market size was valued at $17.28 billion in 2021 and is expected to reach $48.82 billion by 2030, growing at a CAGR of 12.3% from 2022 to 2030.

Download the PDF brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=31347

Browse the table of contents in depth on “Atrial Fibrillation Market”

202 – Pages
126 – Tables
37 – Numbers

Global Atrial Fibrillation Market Overview

Atrial fibrillation is a medical condition that occurs due to abnormal and faulty electrical activities in the atria of the heart. It is a form of cardiac arrhythmia. Generally, atrial fibrillation has no symptoms that can be specifically related to the disease. But in general, it can be identified by symptoms such as fainting, palpitations, congestive heart failure or chest discomfort. Patients with such symptoms can consult the doctor for an ECG which may indicate atrial fibrillation. Depending on the severity of the condition, it is classified into three categories, paroxysmal, persistent and permanent severity. The WHO has stated that atrial fibrillation is the most common form of cardiac arrhythmia. Patients with atrial fibrillation have a much higher chance of producing blood clots that can lead to stroke.

With the growth of the geriatric population, the prevalence of atrial fibrillation has increased dramatically. This created a demand for catheter ablation for cardiac rehabilitation. For this reason, the atrial fibrillation market has also witnessed significant growth in recent years. During the forecast period, with a perfect balance between medical devices used for atrial fibrillation and drugs, the atrial fibrillation market is expected to grow exponentially.

Additionally, increased prevalence of strokes, brain damage, and atrial fibrillation caused by blood clots, along with an expanding elderly population, are driving the expansion of the global atrial fibrillation market. Technological developments in microwave and radiofrequency catheter ablation, along with the increased prevalence of disorders caused by lifestyle choices such as drinking and smoking, are expected to further drive the market growth.

Key players

The main market players are AtriCure Inc., Boston Scientific Corporation, Boehringer Ingelheim GmbH, Biosense Webster Inc., St. Jude Medical Inc., Johnson & Johnson Ltd., CardioFocus Inc., Sanofi-Aventis, Endoscopic Technologies Inc. and Bristol-Myers Squibb Corporation.

Verified Market Research has segmented the global atrial fibrillation market on the basis of procedures and geography.

• Atrial Fibrillation Market, By Procedures
• Pharmacological drugs
• Anti-arrhythmic drugs
• Anticoagulant drugs
• Non-pharmacological treatment
• Catheter ablation procedures
• Radio frequency
• HIFU
• Cryoablation
• Others
• Labyrinth surgery
• Electric cardioversion
• Atrial Fibrillation Market, By Geography
• North America
• Europe
• Germany
• France
• UK
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• LINE
• Middle East & Africa
• Latin America

Browse related reports:

Electrophysiology Devices Market By Product Type (EP Ablation Catheters, EP Diagnostic Catheters), By Indication (Atrial Fibrillation (AF), Wolff-Parkinson-White (WPW) Syndrome), By End-User (Hospitals, diagnostic centers), by geography, and forecast

Implantable Cardiac Monitor Market by Type of Indication (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy and Unexplained Falls), by End User (Hospitals, Ambulatory Surgery Centers and Cardiac Center and Clinics), by Geography and Forecast

Atrial Fibrillation Surgery Market By Procedure (Catheter Ablation Procedures, Surgical/Maze Ablation Procedures), By Product (Catheter Ablation Products Market, Surgical Ablation Market), By Geography and forecasts

Atrial Fibrillation Drugs Market by Product (Antiarrhythmic Drugs, Anticoagulant Drugs), by Type (Paroxysmal, Permanent, Persistent) by Geography and Forecast

Top Cardiac Catheter Sensor Companies Are Fueling the Halted Healthcare Industry

Visualize the Atrial Fibrillation Market using Verified Market Intelligence -:

Verified market intelligence is our BI-enabled platform for storytelling in this market. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a comprehensive overview and global competitive landscape with respect to region, country, segment and key players in your market. Present your market report and results with built-in presentation functionality that saves you over 70% of your time and resources for presentations to investors, sales and marketing, R&D, and product development. VMI enables data delivery in Excel and interactive PDF formats with over 15 key market indicators for your market.

About Us

Verified Market Research is a leading global research and advisory firm serving over 5,000 clients. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and critical revenue decisions.

Our 250 analysts and SMEs offer a high level of expertise in data collection and governance use industry techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study over 14 categories across Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, automotive and transportation, information and communication technology, software and services, information security, mining, minerals and metals, construction. & construction, agricultural industry and medical devices from more than 100 countries.

Contact us
Mr. Edwyne Fernandes
Verified Market Research®
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768
E-mail: [email protected]
The Web: https://www.verifiedmarketresearch.com/
Follow us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

SOURCE Verified Market Research

As electric vehicles (EVs) continue to enter the mainstream automotive market, consumers are more than ever considering buying an EV over a gas-powered vehicle. While there are many benefits to owning an electric car, including lower maintenance costs and less upkeep overall, there are also many exciting new EV features that are often overlooked which would be impressive. and exciting even in a regular gasoline vehicle. The good news is that Kelley Blue Book (KBB) recently put together a list of their favorite electric car features that you can find on electric vehicles today:

Value performance? Buy an electric vehicle with a boost button, says KBB

” src=”https://www.youtube.com/embed/S51ecpzOtU0?feature=oembed” frameborder=”0″ allow=”accelerometer; automatic reading; clipboard-write; encrypted media; gyroscope; picture in picture” allow full screen>

While it’s nothing new to see a car have a performance or sport mode, there aren’t many gas-powered cars that can use a performance-oriented mode like the boost button found in several electric vehicles on the market, including the Genesis GV60.

In this Quarterly Report, the "Company", "we", "its" and "our" refers to Ekso
Bionics Holdings, Inc. and its wholly-owned subsidiaries. The following
discussion of our financial condition and results of operations should be read
in conjunction with the condensed consolidated financial statements and the
notes thereto included elsewhere in this Quarterly Report on Form 10-Q for the
quarter ended September 30, 2022 (this "Quarterly Report") and in our Annual
Report on Form 10-K for the fiscal year ended December 31, 2021, which is
incorporated herein by reference (the "Annual Report").

This Quarterly Report contains forward-looking statements. These forward-looking
statements include statements other than statements of historical facts
contained or incorporated by reference in this Quarterly Report, including
statements regarding (i) the plans and objectives of management for future
operations, including those relating to the design, development and
commercialization of exoskeleton products for humans, (ii) a projection of
income (including income/loss), earnings (including earnings/loss) per share,
capital expenditures, dividends, capital structure or other financial items,
(iii) our future financial performance, including any such statement contained
in a discussion and analysis of financial condition by management or in the
results of operations included pursuant to the rules and regulations of the SEC,
(iv) our beliefs regarding the potential for commercial opportunities for
exoskeleton technology in general and our exoskeleton products in particular,
(v) our beliefs regarding potential clinical and other health benefits of our
medical devices, and (vi) the assumptions underlying or relating to any
statement described in points (i), (ii), (iii), (iv) or (v) above. The words
"may," "might," "would," "should," "could," "project," "estimate," "pro-forma,"
"predict," "potential," "strategy," "anticipate," "attempt," "develop," "plan,"
"help," "believe," "continue," "intend," "expect," "future," and similar
expressions (including the negative of any of the foregoing) are intended to
identify forward-looking statements.

The following factors, among others, including those described in the section
titled "Risk Factors" included in our Annual Report, as updated and supplemented
in this Quarterly Report under the heading "Part II - Item 1A. Risk Factors,"
could cause our future results to differ materially from those expressed in the
forward-looking information:

•our ability to obtain adequate financing to fund operations and to develop or
enhance our technology;
•our ability to obtain or maintain regulatory approval to market our medical
devices;
•our ability to complete clinical trials on a timely basis and that completed
clinical trials will be sufficient to support commercialization of our products;
•the anticipated timing, cost and progress of the development and
commercialization of new products or services, and improvements to our existing
products, and related impacts on our profitability and cash position;
•our ability to effectively market and sell our products and expand our
business, both in unit sales and product diversification;
•our ability to achieve broad customer adoption of our products and services;
•existing or increased competition;
•rapid changes in technological solutions available to our markets;
•volatility with our business, including long and variable sales cycles, which
could have a negative impact on our results of operations for any given quarter;
•changes to our domestic or international sales and operations;
•our ability to obtain or maintain patent protection for our intellectual
property;
•the scope, validity and enforceability of our and third-party intellectual
property rights;
•significant government regulation of medical devices and the healthcare
industry;
•our ability to receive regulatory clearance from certain government
authorities, including any conditions, limitations or restrictions placed on
such approvals;
•our customers' ability to get third-party reimbursement for our products and
services associated with them;
•the potential for our products to be subject to voluntary or involuntary
recall;
•our product liability insurance may not adequately cover potential claims;
•warrant claims and our accelerated maintenance program results in additional
operating costs to us;
•our failure to implement our business plan or strategies;
•our ability to successfully consummate acquisitions on acceptable terms and to
integrate any such acquisitions;
•our early termination of leases, difficulty filling vacancies or negotiating
improved lease terms;
•our ability to retain or attract key employees;
•scope, scale and duration of the impact of outbreaks of a pandemic disease,
such as COVID-19 (coronavirus);
•stock volatility or illiquidity;
•our ability to maintain adequate internal controls over financial reporting;
•the impacts of foreign currency price fluctuations; and

--------------------------------------------------------------------------------
  Table of Contents
•overall economic and market conditions.

Although we believe that the assumptions underlying the forward-looking
statements and forward-looking information contained herein are reasonable, any
of the assumptions could be inaccurate, and therefore, such statements and
information included in this Quarterly Report may not prove to be accurate. In
light of the significant uncertainties inherent in the forward-looking
statements and forward-looking information included herein, the inclusion of
such statements and information should not be regarded as a representation by us
or any other person that the results or conditions described in such statements
and information or that our objectives and plans will be achieved. Such
forward-looking statements speak only as of the date of this Quarterly Report.
Except as required by law, we undertake no obligation to update any
forward-looking statements to reflect events or circumstances after the date of
such statements.

Overview

Our Business

We design, develop, and market exoskeleton products that augment human strength,
endurance and mobility. Our exoskeleton technology serves multiple markets and
can be utilized both by able-bodied persons and by persons with physical
disabilities. We have sold or leased devices that (i) enable individuals with
neurological conditions affecting gait, including ABI, SCI and MS, to
rehabilitate, and in some cases, to walk again, (ii) assist individuals with a
broad range of upper extremity impairments, and (iii) allow industrial workers
to perform difficult repetitive work for extended periods.

We believe that the commercial opportunity for exoskeleton technology adoption
is accelerating as a result of recent advancements in material technologies,
electronic and electrical engineering, control technologies, and sensor and
software development. Taken individually, many of these advancements have become
ubiquitous in peoples' everyday lives. Supported by an industry leading
intellectual property portfolio, we believe that we have learned how to
integrate these existing technologies and wrap the result around a human being
efficiently, elegantly and safely. We further believe this endeavor is
achievable across a broad spectrum of applications, from persons with lower limb
paralysis to able-bodied users.

EksoHealth

EksoHealth is our business unit focused on the development and commercialization of exoskeletons for medical applications.

Our leading product in EksoHealth, the EksoNR, is a robotic exoskeleton used to
provide physical therapy for patients with lower extremity impairment. EksoNR
includes unique features designed specifically to assist physical therapists and
other clinicians to teach patients to walk again after suffering a neurological
impairment. Typical conditions that can be treated with the assistance of EksoNR
include ABIs, such as stroke and traumatic brain injuries, as well as SCIs, MS,
and others. The benefits of EksoNR rehabilitation can include earlier
mobilization of patients, longer and more intense rehab sessions, and increased
quality of sessions as compared to alternative therapies. EksoNR is typically
used in clinical settings, most commonly at inpatient rehab facilities and
stroke centers.

EksoUE, our exoskeleton device for upper limb medical applications, is a wearable upper body exoskeleton used for rehabilitation. EksoUE is designed to help patients with a wide range of upper limb impairments and aims to provide them with a greater active range of motion and increased endurance for higher intensity rehabilitation sessions.

EksoWorks

EksoWorks is our business unit focused on developing, marketing, and selling
exoskeletons and other assistive tools for industrial applications. Target users
for these devices are generally able-bodied, and, as such, the technologies are
primarily employed to reduce worker fatigue. The benefits of fatigue reduction
can include reduced rates of injuries, higher productivity, increased worker
morale, and lower employee turnover. EksoWorks products are primarily sold to
companies deploying the technologies for use directly in their operations.

Our wearable exoskeleton products in EksoWorks include EksoVest and the new EVO,
both of which are designed to support the weight of a worker's arms and tools
during overhead applications, reducing the fatigue associated with working at or
above shoulder height for extended periods. These products are currently
targeted at end users in the aerospace, automotive, manufacturing, and
construction trades.

Before ceasing marketing of the EksoZeroG support arm and associated products and accessories, at the end of the second quarter of 2022, we manufactured and sold our EksoZeroG tool carrier, which could be mounted on a lifting platform or

————————————————– ——————————

  Table of Contents
scaffolding. Refer to Note 6. Revenue Recognition in the notes to our condensed
consolidated financial statements included elsewhere in this Quarterly Report on
Form 10-Q for more information.

Third Quarter 2022 Highlights

• Reservation of a total of 33 EksoNR units in the third quarter of 2022

• Declared turnover of $3.3 million in the third quarter of 2022, a 9% year-over-year increase

•Strong cash position of $29.2 million of the September 30, 2022

Economic and industrial trends

Our revenue is highly dependent on market demand for our exoskeleton products.
This market demand is influenced by many factors including the level of
awareness of robotic exoskeleton rehabilitation among the rehabilitation clinics
with significant ABI and SCI populations, the imperatives among construction and
manufacturing companies to drive adoption of improved safety and health
practices, as well as conditions relating to overall economic growth and general
business activity. Difficult and challenging economic conditions, including
growing supply chain issues amidst an increasingly inflationary environment,
could lead to increased price-based competition. In particular, the effects of
such increasing price-based competition may have an especially significant
impact on certain products that we offer, including the EksoNR, which have a
lengthy sale and purchase order cycle because they are major capital expenditure
items and generally require the approval of senior management at purchasing
institutions. Furthermore, our business includes operations in the Americas,
EMEA and APAC, so we are affected by demand for our products in those regions,
as well as the strengthening or weakening of local currencies relative to the
U.S. Dollar.

The COVID-19 pandemic and related public health measures have also materially
affected how we and our customers are operating our businesses, and have
materially affected our operating results, as demand for our exoskeleton
products decreased as many inpatient rehabilitation facilities temporarily
shifted priorities and delayed capital expenditures. While the duration and
extent to which this will impact our future results remain uncertain, we have
seen certain recovery in the demand for our exoskeleton products following the
gradual reopening and recovery of the broader global economy, and we believe the
clinical need for our products has not diminished, as evidenced by clinical data
showing the increased prevalence of strokes during the pandemic. Although
concerns about the emergence of new, more infectious variants of the coronavirus
remain, we have gradually resumed in-person engagements in addition to virtual
meetings with our current and prospective customers through conferences,
training events and educational demos to offer our support and showcase the
value of our Ekso devices. Further, now that our clinical team is fully
vaccinated and are active onsite at U.S. rehab centers, we expect to see an
uptick in live in-person interactions going forward. Although market
uncertainties related to the pandemic make it difficult for us to project the
full impact on our business and customers, we believe that we are
well-positioned to serve our customers when business conditions begin to
normalize.

Throughout the pandemic, our top priority has been to protect the health and
safety of our employees and our consumers. Employees who are essential to the
daily operations are required to work in our facilities where enhanced personal
protective equipment is in place. In addition, we have a hybrid work from home
and office policy for our employees whose jobs can be performed outside of the
office.

Management continues to actively monitor the global situation, including the
geopolitical instability arising out of military conflict and escalating
tensions between Russia and Ukraine, and its effects on our financial position
and operations.

Management Changes

On January 14, 2022, Jack Peurach, our former President and Chief Executive
Officer, notified us of his intention to resign as an officer and member of the
Board of Directors of the Company to pursue other endeavors. On January 20,
2022, our Board and Mr. Peurach reached an understanding regarding his decision
to leave the Company and entered into an Executive Separation and Release
Agreement pursuant to which Mr. Peurach's last day of service as the President,
Chief Executive Officer and as a member of the Company's Board was January 21,
2022.

In addition, our Board of Directors appointed Steven Sherman, who currently
serves and previously had served as the Chairman of our Board, to become Chief
Executive Officer of the Company effective January 22, 2022. Mr. Sherman
continues to serve as the Chairman of the Board of the Company, and Board member
Stanley Stern has been designated the Board's lead

--------------------------------------------------------------------------------
  Table of Contents
independent director. Furthermore, our Board of Directors appointed Scott Davis
to become President and Chief Operating Officer effective January 22, 2022.

On March 4, 2022, William Shaw, our former Chief Commercial Officer, notified
our Board of Directors of his intention to resign as Chief Commercial Officer of
the Company effective March 11, 2022 in connection with his retention as an
employee at another company.

On May 23, 2022, John F. Glenn our former Chief Financial Officer, notified the
Company of his decision to resign from his position as the Company's Chief
Financial Officer, effective June 17, 2022, in connection with his retention as
an employee at another public company. Mr. Glenn's resignation is not the result
of any dispute or disagreement with the Company including any matters relating
to the Company's accounting practices or financial reporting. On May 25, 2022,
our board of directors approved the appointment of Jerome Wong as Interim Chief
Financial Officer, effective upon Mr. Glenn's departure. Mr. Wong was approved
by our board of directors as Chief Financial Officer, Corporate Secretary and
Principal Financial Officer on October 26, 2022, after serving as Interim Chief
Financial Officer from May 25, 2022 to October 25, 2022.

Significant Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations
is based upon our condensed consolidated financial statements, which have been
prepared in accordance with U.S. GAAP. The preparation of these condensed
consolidated financial statements requires us to make estimates, judgments and
assumptions that affect the reported amounts of assets, liabilities, revenue and
expenses, and the related disclosure of contingent assets and liabilities. We
base our estimates on historical experience and on various other assumptions
that we believe are reasonable under the circumstances. Our estimates form the
basis for our judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results may differ from
these estimates. Our most critical accounting estimates include:

•the standalone selling prices used to allocate the contract consideration to
the individual performance obligations in our device sales arrangements, which
impacts revenue recognition;
•the unobservable inputs and assumptions used by management in estimating the
fair value of our warrant liabilities, which impacts net income or loss;
•the valuation of inventory, which impacts gross profit margins; and
•the estimates made regarding the recoverability of our net deferred tax asset,
which impacts our financial condition.

Autonomous selling prices

Our device sales arrangements contain multiple products and services, most often
including the device(s) and service, both of which we have identified as
distinct performance obligations. Revenue is allocated to each performance
obligation based on its relative standalone selling price. Standalone selling
prices are based on observable prices at which we separately sell the products
or services. If a standalone selling price is not directly observable, then we
estimate the standalone selling prices considering market conditions and
entity-specific factors including, but not limited to, features and
functionality of the products and services, geographies, type of customer, and
gross margin targets. Changes in the relative standalone selling price between
devices and service can have an impact on how transaction prices are allocated
between revenue and deferred revenue.

Responsibilities Related to Warrants

We use the Black-Scholes option-pricing model to value our warrant liabilities
at each reporting period, which requires the input of highly subjective
assumptions, most notably the estimated volatility of our common stock over the
expected term. We use our historical common stock volatility to estimate
expected volatility over the warrant terms. Management must also make uncertain
estimates regarding the likelihood and timing of certain future events for
application of the Lattice Model for the valuation of certain warrants. Changes
in these assumptions could have potential material impacts on the estimated fair
value of warrant liabilities. During the three months ended September 30, 2022,
management made no changes to its estimates regarding the likelihood of future
events, but revised its estimates regarding the timing of future events. We do
not believe the revision resulted in a material impact to the estimated fair
value of warrant liabilities measured using the Lattice Model.


--------------------------------------------------------------------------------
  Table of Contents
Inventory Valuation

Inventory is stated at the lower of cost or net realizable value. Cost is
computed using the standard cost method which approximates actual cost on a
first-in, first-out basis. The cost basis of our inventory is reduced for any
products that are considered excessive or obsolete based upon assumptions about
future demand and market conditions. If actual future demand or market
conditions are less favorable than those projected by management, additional
inventory write-downs may be required, which could have a material adverse
effect on the results of our operations.

Deferred tax asset

We estimate a valuation allowance in consideration of the realizability of our
net deferred tax assets, primarily based on our assessment of the timing,
likelihood and amounts of potential future income during which such items become
deductible. It is inherently difficult and subjective to estimate such amounts,
as we must determine the probability of various possible outcomes and estimate
future amounts. Management does not believe it is more likely than not that we
will generate future income in a timeframe and amount sufficient to realize our
net deferred tax assets. Changes in management's estimate of future income in
the timeframe during which the temporary differences and carryforwards
comprising our deferred tax assets become deductible could result in a material
impact to our financial position including the recognition of a net deferred tax
asset.

Accounting Policies

An accounting policy is considered to be critical if it requires an accounting
estimate to be made based on assumptions about matters that are highly uncertain
at the time the estimate is made, and if different estimates that reasonably
could have been used, or changes in the accounting estimate that are reasonably
likely to occur, could materially impact the condensed consolidated financial
statements. We believe that our critical accounting policies reflect the more
significant estimates and assumptions used in the preparation of the condensed
consolidated financial statements. Refer to Note. 2 Basis of Presentation and
Summary of Significant Accounting Policies and Estimates in the notes to our
condensed consolidated financial statements included elsewhere in this Quarterly
Report on Form 10-Q.

--------------------------------------------------------------------------------
  Table of Contents
Results of Operations

The following table presents our operating results for the three months ended September 30, 2022 and 2021 (in thousands, except percentages):

                                                 Three Months Ended September 30,
                                                    2022                    2021               Change               % Change

Revenue                                      $         3,329           $     3,049          $     280                         9  %
Cost of revenue                                        1,643                 1,242                401                        32  %
Gross profit                                           1,686                 1,807               (121)                       (7) %
Gross profit %                                            51   %                59  %

Operating expenses:
Sales and marketing                                    1,742                 1,685                 57                         3  %
Research and development                                 936                   618                318                        51  %
General and administrative                             2,662                 2,293                369                        16  %

Total operating expenses                               5,340                 4,596                744                        16  %
Loss from operations                                  (3,654)               (2,789)              (865)                       31  %
Other (expense) income, net:
Interest expense                                         (34)                  (24)               (10)                       42  %
Gain on revaluation of warrant liabilities               112                 1,125             (1,013)                      n/m(1)

Unrealized loss on foreign exchange                     (732)                 (268)              (464)                      n/m(1)
Other income (expense), net                                4                    (2)                 6                       n/m(1)
Total other (expense) income, net                       (650)                  831             (1,481)                     (178) %
Net loss                                     $        (4,304)          $    (1,958)         $  (2,346)                      120  %


(1)Not Meaningful


Revenue

Revenue increased $0.3 million, or 9%, for the three months ended September 30,
2022, compared to the same period of 2021. Revenue in the third quarter of 2022
included approximately $3.2 million in EksoHealth revenue and approximately $0.1
million in EksoWorks revenue.

EksoHealth revenue increased approximately $0.5 million for the three months
ended September 30, 2022, compared to the same period of 2021. The increase in
revenue was primarily driven by an increase in the volume of EksoNR device sales
in the EMEA and APAC regions. EksoWorks revenue decreased approximately $0.2
million for the three months ended September 30, 2022, compared to the same
period of 2021. The decrease in EksoWorks revenue was primarily driven by a
reduction in the volume of EVO and EksoVest sales.

Gross profit

Gross profit decreased 7% for the three months ended September 30, 2022 compared
to the same period of 2021, driven by a decrease in gross profit margins in
EksoHealth and EksoWorks segments. Gross margin was approximately 51% for the
three months ended September 30, 2022, compared to a gross margin of 59% for the
same period of 2021. The overall decrease in gross margin was primarily due to
the increase in EksoHealth service costs for both labor and materials usage, and
increases in inventory costs due to the continued global supply shortage.
Additionally, the average selling price for the EksoNR, on an aggregate basis
across all regions, for the three months ended September 30, 2022 decreased 12%
compared to the same period in 2021 as a result of a relative increase of
indirect device sales placed through our distributors. The decrease in gross
margin was partially offset by the relative increase in EksoHealth revenue,
which generally has higher gross margins, in overall revenue composition.

EksoHealth’s service costs have increased due to increased headcount, significant increases in shipping and freight costs related to service activities, and servicing an increased number of client units.

————————————————– ——————————

Contents

Functionnary costs

Research and development expenses increased $0.3 million, or 51%, for the three
months ended September 30, 2022, compared to the same period of 2021, primarily
due to an increase in product development activity mostly related to sustaining
engineering activity for the EksoNR and the development of next generation
products.

General and administrative expenses increased $0.4 millionor 16%, for the three months ended September 30, 2022compared to the same period of 2021, primarily due to increased business development activities and costs associated with our move to our new headquarters and manufacturing facility in
San Rafael, California.

Total other (expense) income, net

Gain on revaluation of warrant liabilities was $0.1 million for the three months
ended September 30, 2022, and was associated with the revaluation of warrants
issued in 2019, 2020 and 2021. Gain on warrant liabilities was $1.1 million for
the three months ended September 30, 2021, and was associated with the
revaluation of warrants issued in 2019, 2020 and 2021. Gains and losses on
revaluation of warrants are primarily driven by changes in our stock price and
the risk-free rate.

Unrealized loss on foreign exchange for the three months ended September 30,
2022 was $0.7 million compared to an unrealized loss on foreign exchange of $0.3
million for the same period of 2021. The unrealized loss was primarily the
result of foreign currency revaluations of our inter-company monetary assets and
liabilities.

The following table presents our operating results for the nine months ended
September 30, 2022 and 2021 (in thousands, except percentages):

                                                  Nine Months Ended September 30,
                                                     2022                    2021               Change               % Change

Revenue                                      $          9,361           $     7,170          $   2,191                        31  %
Cost of revenue                                         4,825                 2,836              1,989                        70  %
Gross profit                                            4,536                 4,334                202                         5  %
Gross profit %                                             48   %                60  %

Operating expenses:
Sales and marketing                                     5,212                 5,265                (53)                       (1) %
Research and development                                2,855                 1,930                925                        48  %
General and administrative                              7,589                 6,415              1,174                        18  %

Total operating expenses                               15,656                13,610              2,046                        15  %
Loss from operations                                  (11,120)               (9,276)            (1,844)                       20  %
Other (expense) income, net:
Interest expense                                          (90)                  (77)               (13)                       17  %
Gain on revaluation of warrant liabilities              1,011                 2,011             (1,000)                      n/m(1)

Gain on forgiveness of note payable                         -                 1,099             (1,099)                      n/m(1)
Unrealized loss on foreign exchange                    (1,704)                 (640)            (1,064)                      n/m(1)
Other income (expense), net                                 1                   (18)                19                      (106) %
Total other (expense) income, net                        (782)                2,375             (3,157)                     (133) %
Net loss                                     $        (11,902)          $    (6,901)         $  (5,001)                       72  %



(1)Not Meaningful

————————————————– ——————————

  Table of Contents
Revenue

Revenue increased $2.2 million, or 31%, for the nine months ended September 30,
2022, compared to the same period of 2021. Revenue for the nine months ended
September 30, 2022 included approximately $8.3 million in EksoHealth revenue and
approximately $1.0 million in EksoWorks revenue.

EksoHealth revenue increased approximately $2.0 million, or 32%, for the nine
months ended September 30, 2022, compared to the same period of 2021. The
increase in revenue was primarily driven by an increase in the volume of EksoNR
device sales in the Americas, EMEA, and APAC regions. EksoWorks revenue
increased approximately $0.2 million, or 19%, for the nine months ended
September 30, 2022, compared to the same period of 2021. The increase in revenue
was primarily related to the recognition of previously deferred prepaid
royalties associated with a license and distribution agreement that expired.

Gross profit

Gross profit increased 5% for the nine months ended September 30, 2022 compared
to the same period of 2021, largely driven by the increase in EksoHealth revenue
as discussed above. Gross margin was approximately 48% for the nine months ended
September 30, 2022, compared to a gross margin of 60% for the same period of
2021. The overall decrease in gross margin was primarily due to an increase in
EksoHealth service costs for both labor and materials usage, and increases in
inventory costs due to the continued global supply shortage. The decrease in
gross margin was partially offset by the recognition of previously deferred
prepaid royalties associated with a license and distribution agreement that
expired.

EksoHealth service costs increased due to increased headcount and the servicing
of an increased number of customer units, owing to the receipt of service parts
during the period, the shortage of which had previously precluded the completion
of service. Additionally, we have experienced significant increases in the cost
of shipping and freight related to service activities.

Functionnary costs

Research and development expenses increased $0.9 million, or 48%, for the nine
months ended September 30, 2022, compared to the same period of 2021, due to an
increase in product development activity mostly related to sustaining
engineering activity for the EksoNR.

General and administrative expenses increased $1.2 million, or 18%, for the nine
months ended September 30, 2022, compared to the same period of 2021, primarily
due to noncash stock-based compensation related to the appointment of our new
Chief Executive Officer, severance expense associated with the departure of our
former Chief Executive Officer, an increase in business development activities,
and costs associated with our move to our new headquarters and manufacturing
facility in San Rafael, California.

Total other (expense) income, net

Gain on revaluation of warrant liabilities was $1.0 million for the nine months
ended September 30, 2022, and was associated with the revaluation of warrants
issued in 2019, 2020 and 2021. Gain on warrant liabilities was $2.0 million for
the nine months ended September 30, 2021, and was associated with the
revaluation of warrants issued in 2019, 2020 and 2021. Gains and losses on
revaluation of warrants are primarily driven by changes in our stock price and
risk free rate.

Gain on forgiveness of note payable of $1.1 million for the nine months ended
September 30, 2021, related to the forgiveness of our PPP Loan. There was no
comparable item in the nine months ended September 30, 2022.

Unrealized loss on foreign exchange for the nine months ended September 30, 2022
was $1.7 million compared to an unrealized loss on foreign exchange of
$0.6 million for the same period of 2021. The unrealized loss was primarily due
to foreign currency revaluations of our inter-company monetary assets and
liabilities.

Cash and capital resources

Since our inception, we have devoted substantially all of our efforts toward the
development and commercialization of exoskeletons for the medical and industrial
markets. and toward raising capital. We have financed our operations primarily
through the issuance and sale of equity securities for cash consideration and
through bank debt.

Cash and capital resources

————————————————– ——————————

Contents

On September 30, 2022, we had working capital of $28.9 million, compared to
working capital of $40.9 million at December 31, 2021. The decrease in working
capital was primarily due to a lower cash balance from cash used in operations.
Our cash as of September 30, 2022, consisted of bank deposits with third party
financial institutions. As of September 30, 2022, of our $29.2 million of cash,
$28.1 million was held domestically while $1.1 million was held by foreign
subsidiaries.

As described in Note 8 in the notes to our condensed consolidated financial
statements included elsewhere in this Quarterly Report on Form 10-Q under the
caption Notes Payable, net, borrowings under our new secured term loan agreement
with Pacific Western Bank have a requirement of minimum cash on hand equivalent
to the current outstanding principal balance. As of September 30, 2022, $2.0
million of cash must remain as restricted. After considering cash restrictions,
effective unrestricted cash as of September 30, 2022 is estimated to be $27.2
million. With this unrestricted cash balance, we believe that we currently have
sufficient cash to fund our operations beyond the look forward period of one
year from the issuance of these condensed consolidated financial statements.

Cash

The following table summarizes the sources and uses of cash (in thousands).

                                                                    Nine 

months ended September 30,

                                                                       2022                    2021
Net cash used in operating activities                          $         (11,044)         $     (8,081)
Net cash used in investing activities                                       (141)                  (60)
Net cash provided by financing activities                                      -                38,712
Effect of exchange rate changes on cash                                      (41)                    6
Net (decrease) increase in cash                                          (11,226)               30,577
Cash at the beginning of the period                                       40,406                12,862
Cash at the end of the period                                  $          29,180          $     43,439

Net cash used in operating activities

Net cash used in operations increased $3.0 million, or 37%, for the nine months
ended September 30, 2022, compared to the same period of 2021 primarily due to
higher payments for business development costs incurred in late 2021, increased
employee compensation, and increased inventory purchases.

Net cash used in investment activities

Net cash used in investing activities increased $0.1 million for the nine months
ended September 30, 2022, compared to the same period of 2021 due to cash
outflows for leasehold improvements for our new headquarters and manufacturing
facility in San Rafael, California.

Net cash provided by financing activities

Net cash provided by financing activities of $38.7 million for the nine months
ended September 30, 2021, was generated from the sale of common stock and
warrants for net proceeds of $36.5 million in connection with the equity
financing, net proceeds of $0.7 million from our "at the market offering"
program, and proceeds of $1.4 million from the exercise of warrants. There was
no comparable amount for the nine months ended September 30, 2022.

Material cash needs

Our material cash requirements include the following items, some of which are
represented in the table of Contractual Obligations and Commitments: (1)
employee wages, benefits and incentives, (2) the procurement of raw materials
and components to support the manufacturing and sale of our products, (3)
expenditures for the ongoing improvement and development of existing and new
technologies, (4) debt repayments (for additional information see Note 8 in the
notes to our condensed consolidated financial statements included elsewhere in
the Quarterly Report on Form 10-Q), and (5) operating lease payments (for
additional information see Note 9 in the notes to our condensed consolidated
financial statements included elsewhere in the Quarterly Report on Form 10-Q).


--------------------------------------------------------------------------------
  Table of Contents
We plan on utilizing our existing unrestricted cash balance to fund our material
cash requirements in the short and long term.

Contractual obligations and commitments

The following table summarizes our outstanding contractual obligations as of
September 30, 2022, and the effect those obligations are expected to have on our
liquidity and cash flows in future periods (in thousands):

                                                        Payments Due By Period:
                                                     Less than
                                         Total        One Year       1-3 Years       3-5 Years
Note payable, principal and interest   $ 2,124      $    2,124      $        -      $        -
Facility operating leases                1,579             314             822             443
Purchase obligations                     3,203           3,203               -               -
Total                                  $ 6,906      $    5,641      $      822      $      443



In response to, or in anticipation of, supplier disruptions and extended lead
times, we may stockpile certain components or raw materials to help prevent
disruption in our production of the EksoNR. Such purchasing behavior is a
contributing factor to the increase in purchase obligations as compared to prior
periods. These actions have, and could continue to have, a short-term adverse
impact on our cash used in operating activities and increase our inventory
balance. Obligations related to these activities are reflected in the line
purchase obligations in the table above.

Refer to Note 13. Commitments and Contingencies in the notes to our condensed
consolidated financial statements included elsewhere in this Quarterly Report on
Form 10-Q for additional information regarding our license agreements, purchase
obligations, and lease commitments.

© Edgar Online, source Previews

Waterborne Coatings Market by Resin Type (Acrylic, Polyester, Alkyd, Epoxy, Polyurethane, PTFE, PVDF, PVDC), Application (Architectural and Industrial), Region (APAC, North America, Europe, MEA, Americas from South)

The Global waterborne coatings market the size was USD 77.9 billion in 2020 and is expected to grow at a CAGR of 3.5% over the forecast period to reach USD 117.7 billion by 2026. The growing demand for the product in applications architectural, such as residential and non-residential construction, and industrial applications such as automotive, packaging, construction, wood and general industry, coupled with their underlying growth, are the key driver of the growth of the water-based coatings market.

New rules and regulations implemented by the European Commission aim to create a greener environment with minimal harmful emissions. Automakers play an important role in minimizing carbon emissions and have begun to adopt these regulations to achieve sustainable growth. Currently, countries in the Middle East region are transforming due to the development of sustainability policies, changing consumer preferences regarding automobile ownership, and the rise of new technologies. South America is an emerging market, offering significant expansion opportunities for coating resin manufacturers. Industrial activities in the region have increased due to increasing disposable income, the move towards nuclear families, affordable interest rates and changing consumer preferences. Emergence of new applications and expansion of existing applications are expected to drive the coating resins market in the region.

Get a PDF brochure for Research Insights at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=205422792

Based on resin type, acrylic segment is expected to be the largest resin type during the forecast period. Water-based acrylic coatings resist weathering and oxidation better than oil-based paints and alkyds. These coatings also provide a polymeric structure that is less likely to absorb ultraviolet light, helping to retain gloss and color for longer periods.

Based on the application, architectural coatings are estimated to account for the largest share of the market during the forecast period. Waterborne coatings are mainly used in architectural application in European and North American countries due to strict regulations in these regions compared to APAC and other smaller regions. Water-based coatings are widely used in architectural applications because it is an inexpensive material that provides water resistance, good stain protection, and good water resistance. The number of initiatives supports the growth of the market, globally.

Players such as PPG Industries Inc., (USA), Nippon Paint Holdings Co., Ltd. (Japan) and AkzoNobel NV (Netherlands) have adopted various strategies, such as investment and expansion and merger and acquisition between 2017 and 2021, to improve their market shares and expand their global presence . New product launches have been an important strategy adopted by market players. Increasing investment in the market along with support through government policies and subsidies is driving the growth of the market in architectural and industrial applications.

For any questions related to the report, ask an analyst at https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=205422792

Sherwin-Williams Company (USA) was the leading company in the global waterborne coatings market in 2021. It has a diversified coatings company and a leading supplier of liquid and powder coatings of advanced technology for the global OEM market through 15 manufacturing sites and 79 installation sites. in the United States, Canada, Mexico and China. The company has a broad product portfolio that includes brands such as Sherwin-Williams, Dutch Boy’s HGTV HOME, Krylon, Minwax and Thompson’s Water Seal. Sherwin-Williams has a strong customer base and operates in various countries in Europe, North America, Asia-Pacific and other regions. The company has increased its growth year on year by innovating on its existing products. The product schedule indicates that it has continuously added new developed products to the existing product line. As part of its growth strategy and to meet the growing demand for water-based coatings in the architectural, energy and construction sectors, the company has entered into joint ventures with other manufacturers. In October 2020, Sherwin-Williams launched Pro Industrial Pre-Catalyzed Waterborne Urethane, a one-component product but with performance attributes comparable to a two-part coating, helps professionals meet the aesthetic and performance needs of industrial or light commercial environments.

PPG Industries, Inc. manufactures and distributes coatings, optical and specialty materials, and glass products. The Company operates through two segments, namely industrial and healthcare. It also provides industrial and automotive coatings to manufacturing companies, adhesives and sealants to the automotive industry, metal pretreatments and related chemicals for industrial and automotive applications, and packaging coatings to aerosol manufacturers, of food and beverages. It has 150 manufacturing sites around the world in countries in North America, Asia-Pacific, South America, Middle East and Africa and Europe. The company has undergone various acquisitions and expansions, large and small. The company’s main acquisition is that of Tikkurila, headquartered in Vantaa, Finland, which is a leading producer and distributor of decorative coatings with operations in 11 countries. Tikkurila has a strong presence in Nordic countries and Eastern Europe. This acquisition provided the company with additional customary benefits, such as expanding its customer base in the Nordics and Eastern Europe. In June 2021, PPG announced the expansion of its coatings manufacturing capacity in Europe for packaging applications. The investment is expected to meet growing customer demand in the region for next-generation coatings for aluminum and steel cans used in beverage, food and personal care packaging.

Share your needs and get custom reports at https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=205422792

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats that will impact 70%-80% of global business revenue. Currently serving 7,500 customers worldwide, including 80% of global Fortune 1000 companies as customers. Nearly 75,000 senior executives from eight industries around the world approach MarketsandMarkets for their revenue decision issues.

Our 850 full-time analysts and MarketsandMarkets SMEs track global high-growth markets by following the “Growth Commitment Model – GEM”. The GEM aims for proactive collaboration with customers to identify new opportunities, identify most important customers, write “Attack, Avoid and Defend” strategies, identify additional sources of revenue for the company and its competitors. MarketsandMarkets now offers 1,500 micro quadrants (positioning of top players among Leaders, Emerging Companies, Innovators, Strategic Players) each year in high-growth emerging segments. MarketsandMarkets is determined to benefit over 10,000 companies this year for their revenue planning and help them bring their innovations/disruptions to market by providing research ahead of the curve.

MarketsandMarkets’ flagship competitive intelligence and market research platform, “Knowledge store”, connects over 200,000 markets and entire value chains for a deeper understanding of unmet information, as well as market sizing and niche market forecasts.

Media Contact
Company Name: MarketsandMarkets Research Private Ltd.
Contact person: Mr. Aashish Mehra
E-mail: Send an email
Call: 18886006441
Address:630 Dundee Road, Suite 430
Town: Northbrook
State: IT 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/waterborne-waterbased-coatings-market-205422792.html

It is an ever-changing world and Malta must continue to diversify its economy without neglecting the central pillar of manufacturing, EU official and potential MEP candidate Peter Agius said during a visit to ST micro electronics.

Agius was welcomed by ST Management Laurent Filipozzi and Philippe Zammit and visited the company’s facilities in Kirkop. ST Microelectronics celebrated 40 years of business in Malta last year. The company produces high-tech components primarily for the automotive industry, employing over 1,800 staff in Malta alone.

“At ST, I felt the irresistible force of a company charting a course for greater success, confident in its strengths: a dynamic Maltese and international workforce and constant innovation. I met operators, engineers, technicians and leaders, all sharing a deep commitment to excellence in every detail, from health and safety to improving energy efficiency, including training and innovation. said Pierre Agius

“Our membership of the EU must be a vector for safeguarding and increasing the competitiveness of Maltese companies. Ongoing negotiations on state aid, transport, FDI, corporate rules and EU taxation must take into account the size and character of our economy. If we want manufacturing to continue to thrive in Malta, we need to adapt EU rules to suit us better. We joined a union after painstaking negotiations on all its aspects 20 years ago. This union is constantly evolving and we must continue to negotiate the best deal for our companies and our workers. added Dr. Agius.

Peter Agius, former head of the European Parliament’s office in Malta and speechwriter to President Antonio Tajani, launched his candidacy to run as an MEP candidate earlier this month. A veteran of the European institutions where he has worked since Malta joined, Agius regularly insists on the need to adapt EU policies to the particular needs of Maltese realities with a view to the greater benefit of the Union to all. sectors of Maltese society.

“Malta can derive greater benefit from the European Union if we become more effective in representing Maltese interests in Brussels and further sensitize and empower our communities in Malta. This is why I vouch to be your voice as an MEP, representing Malta with renewed energy so that we can reap more concrete results from EU membership,” Agius concluded. .

Isipho Capital Motors Shelly Beach is a proud member of the Express Bosch Car Service network.

Bosch Service is a market leader in automotive service workshops with more than 17,000 certified workshops in 150 countries.

Now at Shelly Beach, the professional team is ready and equipped to service and repair all makes of vehicles.

At Isipho Capital Motors, they are extremely rigorous in their approach to the quality, safety and performance levels of all their products. They match the best part for your vehicle, down to the smallest detail. They stock a wide variety of OEM parts and replacements and deliver them to customers within acceptable service levels to minimize your vehicle downtime.

Daya Reddy, Bosch Service Center Shelly Beach Manager, said: “Your car needs regular maintenance to keep it running smoothly. We service all makes and models of petrol and diesel vehicles and offer minor and major services, depending on your needs. Services may include a full safety check and diagnostics, as well as replacement or maintenance of engine oil, oil filters, spark plugs, brakes, fluid levels, lights, air conditioning and more.

Bosch Genuine Parts from the Bosch Service Center are rated among the best in the world and come with a 12 month warranty. Skilled and professional technicians use the latest diagnostic tools to identify and fix problems before they become costly repairs.

Whether you need a repair, seasonal maintenance or a trip check-up, your vehicle, whatever its brand, will be in good hands. From mechanical to electrical and diesel technology, Bosch’s Shelly Beach Service Center is the expert and works with state-of-the-art testing technology.

Want to keep your car in top condition, book it at the Bosch Car Service Center Shelly Beach, corner Marine Drive and Sparrow Road, Shelly Beach. Call them on 039 6820007 or 083 3369386 or email [email protected]

HAVE YOUR SAY

Like the South Coast Herald Facebook page, follow us on Twitter and instagram